Research from San Gallicano Dermatological Institute Provides New Data on Psoriasis [Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)]

MLA

“Research from San Gallicano Dermatological Institute Provides New Data on Psoriasis [Efficacy and Safety of Bimekizumab in Elderly Patients: Real-World Multicenter Retrospective Study - IL PSO (Italian Landscape Psoriasis)].” Health & Medicine Week, 13 Dec. 2024, p. 5012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.819274721&authtype=sso&custid=ns315887.

APA

Research from San Gallicano Dermatological Institute Provides New Data on Psoriasis [Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)]. (2024, December 13). Health & Medicine Week, 5012.

Chicago

Health & Medicine Week. 2024. “Research from San Gallicano Dermatological Institute Provides New Data on Psoriasis [Efficacy and Safety of Bimekizumab in Elderly Patients: Real-World Multicenter Retrospective Study - IL PSO (Italian Landscape Psoriasis)],” December 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.819274721&authtype=sso&custid=ns315887.